Acute renal failure potentiates methylmalonate-induced oxidative stress in brain and kidney of rats

References

• Deodato F, Boenzi S, Santorelli FM, Dionisi-Vici C. Methylmalonic and propionic aciduria. Am J Med Genet 2006;15:104–112.
   Google Scholar
• Fenton WA, Gravel RA, Rosenblatt DS. Disorders of propionate and methylmalonate metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds.). The metabolic and molecular bases of inherited disease. New York: Mcgraw-Hill; 2001. pp. 2165–2193.
   Google Scholar
• Zwickler T, Haege G, Riderer A, Hörster F, Hoffmann GF, Burgard P, Kölker S. Metabolic decompensation in methylmalonic aciduria: which biochemical parameters are discriminative?J Inherit Metab Dis 2012;5:797–806.
   Google Scholar
• Baumgartner ER, Viardot C, and 47 colleagues from 39 hospitals from 7 European countries. Long-term follow-up of 77 patients with isolated methylmalonic aciduria. J Inherit Metab Dis. 1995;18:138–142.
   PubMedGoogle Scholar
• Tu WJ. Methylmalonic acidemia in mainland China. Ann Nutri Metab 2011;58:281.
   PubMedGoogle Scholar
• Brusque AM, Borba Rosa R, Schuck PF, Dalcin KB, Ribeiro CA, Silva CG, . Inhibition of the mitochondrial respiratory chain complex activities in rat cerebral cortex by methylmalonic acid. Neurochem Int 2002;40:593–601.
   PubMed Web of Science ®Google Scholar
• Schuck PF, Rosa RB, Pettenuzzo LF, Sitta A, Wannmacher CM, Wyse AT, Wajner M. Inhibition of mitochondrial creatine kinase activity from rat cerebral cortex by methylmalonic acid. Neurochem Int 2004;45:661–667.
   PubMedGoogle Scholar
• Royes LF, Fighera MR, Furian AF, Oliveira MS, Silva LG, Malfatti CR, . Creatine protects against the convulsive behavior and lactate production elicited by the intrastriatal injection of methylmalonate. Neuroscience 2003;118: 1079–1090.
   PubMed Web of Science ®Google Scholar
• Fleck J, Ribeiro MC, Schneider CM, Sinhorin VD, Rubin MA, Mello CF. Intrastriatal malonate administration induces convulsive behaviour in rats. J Inherit Metab Dis 2004;27: 211–219.
   PubMedGoogle Scholar
• Pettenuzzo LF, Ferreira GC, Schmidt AL, Dutra-Filho CS, Wyse ATS, Wajner M. Differential inhibitory effects of methylmalonic acid on respiratory chain complex activities in rat tissues. Int J Dev Neurosci 2006;24:45–52.
   PubMed Web of Science ®Google Scholar
• Melo DR, Kowaltowski AJ, Wajner M, Castilho RF. Mitochondrial energy metabolism in neurodegeneration associated with methylmalonic acidemia. J Bioenerg Biomembr 2011;43:39–46.
   PubMedGoogle Scholar
• Brusque AM, Rotta LN, Tavares RG, Emanuelli T, Schwarzbold CV, Dutra-Filho CS, . Effects of methylmalonic and propionic acids on glutamate uptake by synaptosomes and synaptic vesicles and on glutamate release by synaptosomes from cerebral cortex of rats. Brain Res 2001;920:194–201.
   PubMed Web of Science ®Google Scholar
• Loureiro SO, de Lima Pelaez SO, Heimfarth L, Souza DO, Wajner M, Pessoa-Pureur R. Propionic and methylmalonic acids increase cAMP levels in slices of cerebral cortex of young rats via adrenergic and glutamatergic mechanisms. Biochimica et Biophysica Acta 2005;174:460–466.
   Google Scholar
• Fontella F, Pulronick V, Gassen E, Wannmacher CMD, Klein AB, Wajner M, Dutra-Filho CS. Propionic and L-methylmalonic acids induce oxidative stress in brain of young rats. Neuroreport 2000;28:541–544.
   Google Scholar
• Fernandes CG, Borges CG, Seminotti S, Amaral AU, Knebel LA, Eichler P, . Experimental evidence that methylmalonic acid provokes oxidative damage and compromises antioxidant defenses in nerve terminal and striatum of young rats. Cell Mol Neurobiol 2011;31:775–785.
   PubMed Web of Science ®Google Scholar
• Kashtan CE, Abousedira M, Rozen S, Manivel JC, McCann M, Tuchman M. Chronic administration of methylmaloic acid (MMA) to rats causes proteinuria and renal tubular injury (abstract). Pediatr Res 1998;43:309.
   Google Scholar
• Dutra JC, Wajner M, Wannmacher CMD, Wannmacher LE, Pires RF, Rosa-Júnior A. Effect of postnatal methylmalonate administration on adult rat behavior. Braz JMed Biol Res 1991;24:595–605.
   PubMedGoogle Scholar
• Petronilho F, Constantino L, Souza B, Reinke A, Martins MR, Fraga CM, . Efficacy of the combination of n-acetylcysteine and desferrioxamine in the prevention and treatment of gentamicin-induced acute renal failure in male wistar rats. Nephrol Dial Transplant 2009;24:2077–2082.
   PubMed Web of Science ®Google Scholar
• Evelson P, Travacio M, Repetto M, Escobar, Llesuy S, Lissi EA. Evaluation of total reactive antioxidant potential (trap) of tissue homogenates and their cytosols. Arch Biochem Biophys 2001;388:261–266.
   PubMed Web of Science ®Google Scholar
• Poderoso JJ, Carreras MC, Lisdero C, Riobó N, Schöpfer F, Boveris A. Nitric oxide inhibits electron transfer and increases superoxide radical production in rat heart mitochondria and submitochondrial particles. Arch Biochem Biophys 1996; 328:85–92.
   PubMed Web of Science ®Google Scholar
• Esterbauer H, Cheeseman KH. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 1990;186:407–421.
   PubMed Web of Science ®Google Scholar
• Reznick AZ, Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol 1994;233:357–363.
   PubMed Web of Science ®Google Scholar
• Aksenov MY, Markesbery WR. Changes in thiol content and expression of glutathione redox system genes in the hippocampus and cerebellum in alzheimer's disease. Neurosci Lett 2001;302:141–145.
   PubMed Web of Science ®Google Scholar
• Browne RW, Armstrong D. Reduced glutathione and glutathione disulfide. Methods Mol Biol 1998;108:347–352.
   PubMedGoogle Scholar
• Lebel CP, Ischiropoulos H, Bondy SC. Evaluation of the probe 2’,7’-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem Res Toxicol 1992;5:227–231.
   PubMed Web of Science ®Google Scholar
• Aebi H. Catalase in vitro. Methods Enzymol 1984;105: 121–126.
   PubMed Web of Science ®Google Scholar
• Bannister JV, Calabrese L. Assays for SOD. Methods Biochem Anal 1987;32:279–312.
   PubMedGoogle Scholar
• Wendel A. Glutathione peroxidase. Methods Enzymol 1981;77:325–332.
   PubMedGoogle Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951;1936:265–275.
   Google Scholar
• Fenton WA, Hack AM, Willard HF, Gertler A, Rosenberg LE. Purification and properties of methylmalonyl coenzyme A mutase from human liver. Arch Biochem Biophys 1982; 214:815–823.
   PubMedGoogle Scholar
• Kennedy DG, Cannavan A, Molloy A, O'harte F, Taylor SM, Kennedy S, Blanchflower WJ. Methylmalonyl-coA mutase (EC 5.4.99.2) and methionine synthetase (EC 2.1.1.13) in the tissues of cobalt-vitamin B12 deficient sheep. Br J Nutr 1990;64:721–732.
   PubMedGoogle Scholar
• Chandler RJ, Sloan J, Fu H, Tsai M, Stabler S, Allen R, . Metabolic phenotype of methylmalonic acidemia in mice and humans: the role of skeletal muscle. BMC Med Genet 2007;8:64.
   PubMedGoogle Scholar
• Nicolaides P, Leonard J, Surtees R. Neurological outcome of methylmalonic acidaemia. Arch Dis Child 1998;78:508–512.
   PubMedGoogle Scholar
• D'angio CT, Dillon MJ, Leonard JV. Renal tubular dysfunction in methylmalonic acidaemia. Eur J Pediatr 1991;150: 259–263.
   PubMedGoogle Scholar
• Van Calcar SC, Harding CO, Lyne P, Hogan K, Banerjee R, Sollinger H, . Renal transplantation in a patient with methylmalonic acidaemia. J Inherit Metab Dis 1998;21:729–737.
   PubMedGoogle Scholar
• Srinivas KW, Want MA, Freigoun OS, Balakrishna N. Methylmalonic acidemia with renal involvement: a case report and review of literature. Saudi JKidney Dis Transpl 2001; 12:49–53.
   PubMedGoogle Scholar
• Morath MA, Okun JG, Müller IB, Sauer SW, Hörster F, Hoffmann GF, Kölker S. Neurodegeneration and chronic renal failure in methylmalonicaciduria – a pathophysiological approach. J Inherit Metab Dis 2008;31:35–43.
   PubMed Web of Science ®Google Scholar
• Halperin ML, Schiller CM, Fritz IB. The inhibition by methylmalonic acid of malate transport by the dicarboxylate carrier in rat liver mitochondria.a possible explantation for hypoglycemia in methylmalonic acidúria. J Clin Invest 1971;50: 2276–2282.
   PubMedGoogle Scholar
• Toyoshima S, Watanabe F, Saido H, Miyatake K, Nakano Y. Methylmalonic acid inhibits respiration in rat liver mitochondria. J Nutr 1995;125:2846–2850.
   PubMedGoogle Scholar
• Mirandola SR, Melo DR, Schuck PF, Ferreira GC, Wajner M, Castilho RF. Methylmalonate inhibits succinate-supported oxygen consumption by interfering with mitochondrial succinate uptake. J Inherit Metab Dis 2008;31:44–54.
   PubMed Web of Science ®Google Scholar
• Perez-Severiano F, Rios C, Segovia J. Striatal oxidative damage parallels the expression of a neurological phenotype in mice transgenic for the mutation of Huntington's disease. Brain Res 2000;862:234–237.
   PubMed Web of Science ®Google Scholar
• Bogdanov MB, Andreassen OA, Dedeoglu A, Ferrante RJ, Beal MF. Increased oxidative damage to DNA in a transgenic mouse of Huntington's disease. J Neurochem 2001;79: 1246–1249.
   PubMed Web of Science ®Google Scholar
• Behl C, Moosmann B. Oxidative nerve cell death in Alzheimer's disease and stroke: antioxidants as neuroprotective compounds. J Biol Chem 2002;383:521–536.
   Google Scholar
• Stoy N, Mackay GM, Forrest CM, Christofides J, Egerton M, Stone TW, Darlington LG. Tryptophan metabolism and oxidative stress in patients with Huntington's disease. J Neurochem 2005;93:611–623.
   PubMed Web of Science ®Google Scholar
• Latini A, Scussiato K, Rosa RB, Llesuy S, Bello-Klein A, Dutra-Filho CS, Wajner M. D-2-hydroxyglutaric acid induces oxidative stress in cerebral cortex of young rats. Eur J Neurosci 2003;17:2017–2022.
   PubMed Web of Science ®Google Scholar
• Ribas GS, Pires R, Coelho JC, Rodrigues D, Mescka CP, Vanzin CS, . Oxidative stress in Niemann-Pick type C patients: a protective role of N-butyl-deoxynojirimycin therapy. Int J Dev Neurosci 2012;30:439–444.
   PubMed Web of Science ®Google Scholar
• Marques FO, Hagen ME, Pederzolli CD, Sgaravatti AM, Durigon K, Testa CG, . Glutaric acid induces oxidative stress in brain of young rats. Brain Res 2003;964:153–158.
   PubMedGoogle Scholar
• Kölker S, Mayatepek E, Hoffmann GF. White matter disease in cerebral organic acid disorders: clinical implications and suggested pathomechanisms. Neuropediatrics 2002;33: 225–231.
   PubMedGoogle Scholar
• Balakumar P, Rohilla A, Thangathirupathi A. Gentamicin-induced nephrotoxicity: do we have a promising therapeutic approach to blunt it?Pharmacol Res 2010;62:179–186.
   PubMed Web of Science ®Google Scholar
• Halliwell B, Gutteridge JMC. Measurement of reactive species. In: Halliwell B, Gutteridge JMC (eds.). Free radicals in biology and medicine. Oxford: Oxford University Press; 2007. pp. 268–340.
   Google Scholar
• Levine RL, Williams JA, Stadman ER, Shacter E, Lissi E, Pascual C, Del Castillo MD. Luminol luminescence induced by 2,2’-azo-bis(2-amidinopropane) thermolysis. Free Radic Res Commun 1992;17:299–311.
   PubMedGoogle Scholar
• Requejo R, Hurd TR, Costa NJ, Murphy MP. Cysteine residues exposed on protein surfaces are the dominant intramitochondrialthiol and may protect against oxidative damage. FEBS J 2010;227:1465–1480.
   Google Scholar
• Davies MJ. Singlet oxygen-mediated damage to proteins and its consequences. Biochem Biophys Res Commun 2003;305:761–770.
   PubMed Web of Science ®Google Scholar
• Ischiropoulos H, Gow A, Thom SR, Kooy NW, Royall JA, Crow JP. Detection of reactive nitrogen species using 2, 7-dichlorodihydrofluorescein and dihydrorhodamine 123. Methods Enzymol 1999;301:367–373.
   PubMed Web of Science ®Google Scholar
• Ohashi T, Mizutani A, Murakami A, Kojo S, Ishii T, Taketani S. Rapid oxidation of dichlorodihydrofluorescin with heme and hemoproteins: formation of the fluorescein is independent of the generation of reactive oxygen species. FEBS Lett 2002;511:21–27.
   PubMed Web of Science ®Google Scholar
• Myhre O, Andersen JM, Aarnes H, Fonnum F. Evaluation of the probes 20,70-dichlorofluorescin diacetate, luminol, and lucigenin as indicators of reactive species formation. Biochem Pharmacol 2003;65:1575–1582.
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Tan DX, Manchester LC, Qi W. Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence. Cell Biochem Biophys 2001; 34:237–256.
   PubMed Web of Science ®Google Scholar
• Anisimov VN, Popovich IG, Zabezhinski MA, Anisimov SV, Vesnushkin GM, Vinogradova IA. Melatonin as antioxidant, geroprotector and anticarcinogen. Biochim Biophys Acta 2006;1757:573–589.
   PubMed Web of Science ®Google Scholar
• Karelson E, Bogdanovic N, Garlind A, Winblad B, Zilmer K, Kullisaar T, . The cerebrocortical areas in normal brain aging and in Alzheimer's disease: noticeable differences in the lipid peroxidation level and in antioxidant defense. Neurochem Res 2001;26:353–361.
   PubMed Web of Science ®Google Scholar
• Hayasaka K, Metoki K, Satoh T, Narisawa K, Tada K, Kawakami T, . Comparison of cytosolic and mitochondrial enzyme alterations in the livers of propionic or methylmalonic acidemia: a reduction of cytochrome oxidase activity. Tohoku J Exp Med 1982;137:329–334.
   PubMedGoogle Scholar
• Ostergaard E, Wibrand F, Orngreen MC, Vissing J, Horn N. Impaired energy metabolism and abnormal muscle histology in mut- methylmalonic aciduria. Neurology 2005;65: 931–933.
   PubMedGoogle Scholar
• Chandler RJ, Zerfas PM, Shanske S, Sloan J, Hoffmann V, Dimauro S, Venditti CP. Mitochondrial dysfunction in mut-methylmalonic acidemia. FASEB J 2009;23:1252–1261.
   PubMed Web of Science ®Google Scholar